相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular characterization of Helicobacter pylori resistance to rifamycins
Constantin Hays et al.
HELICOBACTER (2018)
Furazolidone treatment for Helicobacter Pylori infection: A systematic review and meta-analysis
Liya Zhuge et al.
HELICOBACTER (2018)
How to eliminate gastric cancer-related death worldwide?
Yoshio Yamaoka
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Tuberculosis in South Asia: a tide in the affairs of men
Buddha Basnyat et al.
MULTIDISCIPLINARY RESPIRATORY MEDICINE (2018)
Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China
Yong Xie et al.
HELICOBACTER (2018)
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report
P. Malfertheiner et al.
GUT (2017)
Applicability of the shorter 'Bangladesh regimen' in high multidrug- resistant tuberculosis settings
Giovanni Sotgiu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Antibiotic resistance and gyrA mutation affect the efficacy of 10-day sitafloxacin-metronidazole-esomeprazole therapy for Helicobacter pylori in penicillin allergic patients
Hideki Mori et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
Antibiotic resistance in Helicobacter pylori
Claudio Alba et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2017)
Furazolidone, an Underutilized Drug for H-pylori Eradication: Lessons from Iran
Marjan Mohammadi et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Enteric Fever Caused by Salmonella enterica Serovars with Reduced Susceptibility of Fluoroquinolones at a Community Based Teaching Hospital of Nepal
Anjeela Bhetwal et al.
INTERNATIONAL JOURNAL OF MICROBIOLOGY (2017)
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal
Muhammad Miftahussurur et al.
BMC MICROBIOLOGY (2016)
Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex
Zenda L. Berrada et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)
Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies
Antonio Francesco Ciccaglione et al.
HELICOBACTER (2016)
Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem
Yue Hu et al.
HELICOBACTER (2016)
Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance
Hafeza Aftab et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2016)
High Helicobacter pylori cure rate with sitafloxacin-based triple therapy
M. Sugimoto et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Mechanisms of drug resistance: quinolone resistance
David C. Hooper et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS (2015)
Antibiotic susceptibility of Lactobacillus strains isolated from domestic geese
M. Dec et al.
BRITISH POULTRY SCIENCE (2015)
Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections
John A. Crump et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study
Yue-Xi Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: Comparing agar dilution, E-test, and disk diffusion
Silvio Kazuo Ogata et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2014)
THE QUEST FOR THE BEST METRIC OF ANTIBIOTIC USE AND ITS CORRELATION WITH THE EMERGENCE OF FLUOROQUINOLONE RESISTANCE IN CHILDREN
Lucia Rose et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection
Yong Xie et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials
Alexander C. Ford et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Extremely high prevalence of Helicobacter pylori infection in Bhutan
Ratha-korn Vilaichone et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Review article: rifabutin in the treatment of refractory Helicobacter pylori infection
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Observation of Gastric Mucosa in Bangladesh, the Country with the Lowest Incidence of Gastric Cancer, and Japan, the Country with the Highest Incidence
Takeshi Matsuhisa et al.
HELICOBACTER (2012)
Fluoroquinolone Resistance in Helicobacter pylori: Role of Mutations at Position 87 and 91 of GyrA on the Level of Resistance and Identification of a Resistance Conferring Mutation in GyrB
Emiko Rimbara et al.
HELICOBACTER (2012)
The Beginning of the rpoB Gene in Addition to the Rifampin Resistance Determination Region Might Be Needed for Identifying Rifampin/Rifabutin Cross-Resistance in Multidrug-Resistant Mycobacterium tuberculosis Isolates from Southern China
Yaoju Tan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Helicobacter pylori: usefulness of an empirical fourth-line rifabutin-based regimen
Mario M. D'Elios et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Furazolidone in Helicobacter Pylori Therapy: Misunderstood and Often Unfairly Maligned Drug Told in a Story of French Bread
David Y. Graham et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2012)
Helicobacter pylori Resistance to Rifabutin in the Last 7 Years
Toshihiro Nishizawa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Helicobacter pylori treatment in the era of increasing antibiotic resistance
David Y. Graham et al.
GUT (2010)
Sitafloxacin and Garenoxacin May Overcome the Antibiotic Resistance of Helicobacter pylori with gyrA Mutation
Hidekazu Suzuki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Sitafloxacin Activity against Helicobacter pylori Isolates, Including Those with gyrA Mutations
Kazunari Murakami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs
Marta Sousa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance
Zhi-Qiang Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Molecular characterization of intrinsic and acquired antibiotic resistance in lactic acid bacteria and bifidobacteria
Mohammed Salim Ammor et al.
JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY (2008)
Long-term re-infection rate after Helicobacter pylori eradication in Bangladeshi adults
Mian Mashhud Ahmad et al.
DIGESTION (2007)
Microbial drug efflux proteins of the major facilitator superfamily
Massoud Saidijam et al.
CURRENT DRUG TARGETS (2006)
Rifaximin: A novel nonabsorbed rifamycin for gastrointestinal disorders
JA Adachi et al.
CLINICAL INFECTIOUS DISEASES (2006)
Eradication of Helicobacter pylori: Are rifaximin-based regimens effective?
A Gasbarrini et al.
DIGESTION (2006)
Mechanisms of resistance to quinolones
GA Jacoby
CLINICAL INFECTIOUS DISEASES (2005)
Compound efflux in Helicobacter pylori
A Kutschke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Rifaximin, a poorly absorbed antibiotic: Pharmacology and clinical potential
C Scarpignato et al.
CHEMOTHERAPY (2005)
Evaluation of the carcinogenic effects of furazolidone and its metabolites in two fish species
A Auro et al.
PHARMACOGENOMICS JOURNAL (2004)
High-level β-lactam resistance associated with acquired multidrug resistance in Helicobacter pyloti
DH Kwon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects
DA Gajjar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756
JC Fung-Tomc et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Mutations at four distinct regions of the rpoB gene can reduce the susceptibility of Helicobacter pylori to rifamycins
M Heep et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
